Synthesis of C-β-D-glucopyranosyl derivatives of some fused azoles for the inhibition of glycogen phosphorylase

被引:7
作者
Szennyes, Eszter [1 ]
Bokor, Eva [1 ]
Docsa, Tibor [2 ]
Sipos, Adam [2 ]
Somsak, Laszlo [1 ]
机构
[1] Univ Debrecen, Dept Organ Chem, POB 400, H-4002 Debrecen, Hungary
[2] Univ Debrecen, Fac Med, Dept Med Chem, Egyet Ter 1, H-4032 Debrecen, Hungary
关键词
C-glycosyl heterocycle; Fused azole; Imidazole; Inhibitor; Glycogen phosphorylase; GLUCOSE ANALOG INHIBITORS; BINDING; NUCLEOSIDES; IMIDAZOLES; REVEAL; MUSCLE;
D O I
10.1016/j.carres.2018.11.003
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Annulated C-beta-D-glucopyranosyl heterocycles were synthesized and tested as inhibitors of glycogen phosphorylase. 2-(beta-D-Glucopyranosyl)-1H-imidazo[4,5-b] pyridine was formed by ring-closure of O-perbenzoylated C-beta-D-glucopyranosyl formic acid with 2,3-diaminopyridine in the presence of triphenylphosphite. Cyclisations of bromomethyl 2,3,4,6-tetra-O-benzoyl-beta-D-glucopyranosyl ketone with a set of 2-aminoheterocycles resulted in constitutionally reversed C-beta-D-glucopyranosyl imidazoles fused by pyridine, pyrimidine, thiazole, 1,3,4-thiadiazole, benzothiazole and benzimidazole. O-Debenzoylation of the above compounds was effected by standard transesterification to get the test compounds. The 1H-imidazo[4,5-b] pyridine proved to be a low micromolar inhibitor (K-i = 21.1 mu M) of rabbit muscle glycogen phosphorylase b, while the other heterocycles displayed weak or no inhibition against the same enzyme.
引用
收藏
页码:33 / 41
页数:9
相关论文
共 50 条
  • [21] Probing the β-pocket of the active site of human liver glycogen phosphorylase with 3-(C-β-D-glucopyranosyl)-5-(4-substituted-phenyl)-1, 2, 4-triazole inhibitors
    Kyriakis, Efthimios
    Solovou, Theodora G. A.
    Kun, Sandor
    Czifrak, Katalin
    Szocs, Bela
    Juhasz, Laszlo
    Bokor, Eva
    Stravodimos, George A.
    Kantsadi, Anastassia L.
    Chatzileontiadou, Demetra S. M.
    Skamnaki, Vassiliki T.
    Somsak, Laszlo
    Leonidas, Demetres D.
    BIOORGANIC CHEMISTRY, 2018, 77 : 485 - 493
  • [22] Synthesis, In Silico and Kinetics Evaluation of N-(β-D-glucopyranosyl)-2-arylimidazole-4(5)-carboxamides and N-(β-D-glucopyranosyl)-4(5)-arylimidazole-2-carboxamides as Glycogen Phosphorylase Inhibitors
    Homolya, Levente
    Mathomes, Rachel T.
    Varga, Luca
    Docsa, Tibor
    Juhasz, Laszlo
    Hayes, Joseph M.
    Somsak, Laszlo
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (09)
  • [23] Binding of N-acetyl-N′-β-D-glucopyranosyl urea and N-benzoyl-N′-β-D-glucopyranosyl urea to glycogen phosphorylase b -: Kinetic and crystallographic studies
    Oikonomakos, NG
    Kosmopoulou, M
    Zographos, SE
    Leonidas, DD
    Chrysina, ED
    Somsák, U
    Nagy, V
    Praly, JP
    Docsa, T
    Tóth, A
    Gergely, P
    EUROPEAN JOURNAL OF BIOCHEMISTRY, 2002, 269 (06): : 1684 - 1696
  • [24] Synthesis, Kinetic and Conformational Studies of 2-Substituted-5-(β-d-glucopyranosyl)-pyrimidin-4-ones as Potential Inhibitors of Glycogen Phosphorylase
    Mavreas, Konstantinos F.
    Neofytos, Dionysios D.
    Chrysina, Evangelia D.
    Venturini, Alessandro
    Gimisis, Thanasis
    MOLECULES, 2020, 25 (22):
  • [25] The architecture of hydrogen and sulfur σ-hole interactions explain differences in the inhibitory potency of C-β-D-glucopyranosyl thiazoles, imidazoles and an N-β-D glucopyranosyl tetrazole for human liver glycogen phosphorylase and offer new insights to structure-based design
    Kyriakis, Efthimios
    Karra, Aikaterini G.
    Papaioannou, Olga
    Solovou, Theodora
    Skamnaki, Vassiliki T.
    Liggri, Panagiota G. V.
    Zographos, Spyros E.
    Szennyes, Eszter
    Bokor, Eva
    Kun, Sandor
    Psarra, Anna-Maria G.
    Somsak, Laszlo
    Leonidas, Demetres D.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2020, 28 (01)
  • [26] C-(2-Deoxy-D-arabino-hex-1-enopyranosyl)-oxadiazoles: synthesis of possible isomers and their evaluation as glycogen phosphorylase inhibitors
    Bokor, Eva
    Szennyes, Eszter
    Csupasz, Tibor
    Toth, Nora
    Docsa, Tibor
    Gergely, Pal
    Somsak, Laszlo
    CARBOHYDRATE RESEARCH, 2015, 412 : 71 - 79
  • [27] N-(4-Substituted-benzoyl)-N′-(β-D-glucopyranosyl)ureas as inhibitors of glycogen phosphorylase: Synthesis and evaluation by kinetic, crystallographic, and molecular modelling methods
    Veronika Nagy
    Nora Felfoeldi
    Balint Konya
    Praly, Jean-Pierre
    Tibor Docsa
    Pal Gergely
    Chrysina, Evangelia D.
    Tiraidis, Costas
    Kosmopoulou, Magda N.
    Alexacou, Kyra-Melinda
    Konstantakaki, Maria
    Leonidas, Demetres D.
    Zographos, Spyros E.
    Oikonomakos, Nikos G.
    Kozmon, Stanislav
    Tvaroska, Igor
    Laszlo Somsak
    BIOORGANIC & MEDICINAL CHEMISTRY, 2012, 20 (05) : 1801 - 1816
  • [28] The binding of β-D-glucopyranosyl-thiosemicarbazone derivatives to glycogen phosphorylase: A new class of inhibitors
    Alexacou, Kyra-Melinda
    Tenchiu , Alia-Cristina
    Chrysina, Evangelia D.
    Charavgi, Maria-Despoina
    Kostas, Ioannis D.
    Zographos, Spyros E.
    Oikonomakos, Nikos G.
    Leonidas, Demetres D.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2010, 18 (22) : 7911 - 7922
  • [29] Computationally motivated synthesis and enzyme kinetic evaluation of N-(β-D-glucopyranosyl)-1,2,4-triazolecarboxamides as glycogen phosphorylase inhibitors
    Begum, Jaida
    Varga, Gergely
    Docsa, Tibor
    Gergely, Pal
    Hayes, Joseph M.
    Juhasz, Laszlo
    Somsak, Laszlo
    MEDCHEMCOMM, 2015, 6 (01) : 80 - 89
  • [30] 1-(3-Deoxy-3-fluoro-β-D-glucopyranosyl) pyrimidine derivatives as inhibitors of glycogen phosphorylase b: Kinetic, crystallographic and modelling studies
    Tsirkone, Vicky G.
    Tsoukala, Evangelia
    Lamprakis, Christos
    Manta, Stella
    Hayes, Joseph M.
    Skamnaki, Vicky T.
    Drakou, Christina
    Zographos, Spyros E.
    Komiotis, Dimitri
    Leonidas, Demetres D.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2010, 18 (10) : 3413 - 3425